“`html
On Monday, Tilray Brands (TLRY), based in Canada, announced its fourth-quarter results for fiscal 2025, which ended in May 2025. The company’s adjusted earnings per share (EPS) were 2 cents, a 50% decline year-over-year, while revenues fell 2% to $224.5 million, missing expectations primarily due to weak sales in its cannabis and beverages segments.
For fiscal 2026, Tilray anticipates adjusted EBITDA between $62 million and $72 million, indicating a growth of 13-31% year-over-year. The company has reported record revenues of $821 million for fiscal 2025, driven largely by non-cannabis sectors, which accounted for about 70% of overall sales. While cannabis revenues dropped 9% to $249 million, international cannabis sales rose 19% but remain a minor portion of total sales.
Tilray shares have decreased 56% year-to-date, contrasted with a 6% growth in its industry. The company’s focus on diversifying into beverages and THC drinks demonstrates strategic foresight, though ongoing declines in its core cannabis business and competitive pressures pose significant challenges ahead.
“`
